Text Size

New Horizons Forum


The 8th Annual Glaucoma 360 New Horizons Forum — speeding the development of new therapies and diagnostics for glaucoma patients.

February 1, 2019 — The Palace Hotel, San Francisco, CA

The Glaucoma 360 New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice. Online registration opens soon.


Keynote Speaker

2019 Drs. Henry and Frederick Sutro Memorial Lecturer

Janey L. Wiggs, MD, PhD

Paul Austin Chandler Professor of Ophthalmology
Harvard Medical School
Massachusetts Eye and Ear Infirmary

Keynote Lecture:
“Glaucoma Genetics: Working Toward A Cure”

What key opinion leaders are saying about New Horizons Forum:

“Attending New Horizons Forum gives you an amazing lift as you see the terrific innovations that are on the horizon.”
- Reay H. Brown, MD, Atlanta Ophthalmology Associates

“New Horizons is a unique meeting that brings together clinicians, industry members, and patients for an open discussion about the treatment of glaucoma today and in the future.”
- Malik Kahook, MD, University of Colorado School of Medicine

“I've never seen such an effective mix of scientists, doctors, industry, patients, FDA, and venture funding. Enhanced by good food and plentiful coffee. Wow.”
- Benjamin Backus, PhD, Chief Scientific Officer, Vivid Vision, Inc.

“The best one-day event for the field of glaucoma.””
- Eugene de Juan, Jr., MD, Founder and Vice-Chairman, ForSight labs

Who should attend:

  • Early-stage company CEOs and executives
  • Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
  • Key Opinion Leaders and Leading Ophthalmologists
  • Industry Executives
  • Venture Capitalists
  • Representatives from Clinical Research Organizations
  • Scientific innovators



Founder and Co-Chair

Adrienne Graves, PhD
Independent Director: Akorn, Inc., Nicox S.A., Surface Pharmaceuticals, and TearLab Corporation


Founder and Co-Chair

Andrew G. Iwach, MD
Executive Director
Glaucoma Center of San Francisco
Chair, Board of Directors
Glaucoma Research Foundation

New Horizons Advisory Board

Nationally and internationally respected leaders in the field of glaucoma, business, and medical innovation provide leadership for the second annual Glaucoma 360 New Horizons Forum. The Advisory Board is actively involved, along with the Program Committee, in planning the meeting and recommending engaging speakers, noteworthy panelists, and timely topics.

View the New Horizons Advisory Board »


The 8th annual New Horizons Forum, a full-day program, will take place February 1, 2019 at the Palace Hotel in San Francisco.

7:30 AM - Registration, Breakfast, and Exhibits

8:00 AM to 5:30 PM - Program

5:30 PM to 7:00 PM - Reception

New Horizons Exhibit Hall — 7:30 AM to 7:00 PM

View the Preliminary Program Agenda »

Download the 2018 New Horizons Forum Program Book (PDF) »

Learn more and Register »

Sponsorship Opportunities

Glaucoma 360 Sponsorship Opportunities »

Please contact Nancy Graydon at 415-986-3162 for exhibiting and sponsorship information.



All Glaucoma 360 events are held at the historic Palace Hotel in San Francisco, California. The Palace is an iconic landmark venue featuring timeless creations such as the Garden Court's stained glass dome and a 1909 Maxfield Parrish mural in the Pied Piper Bar.

The Palace Hotel
2 New Montgomery Street
San Francisco, CA 94105
Phone: (415) 512-1111

Reserve a room at the Palace Hotel for Glaucoma 360 »

New Horizons Forum is part of Glaucoma 360, a series of annual events presented by Glaucoma Research Foundation.

For more information, please email Nancy Graydon at Glaucoma Research Foundation, or call (415) 986-3162.


Proceeds from the New Horizons Forum benefit the Glaucoma Research Foundation for use in our grant-making and other operational priorities.

Last reviewed on October 03, 2018

Was this helpful? Yes No